Deborah Knobelman

Insider Reports History

Location
South San Francisco, CA
Signature
/s/ Deborah Knobelman
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Deborah Knobelman:

Company Role Class Num Shares Value Price $ Report Date Ownership
Senti Biosciences, Inc. Chief Financial Officer, Head of Corporate Development Common Stock 131,000 $571,160 $4.36 01 Feb 2024 Direct
Kronos Bio, Inc. President & Interim CEO Common Stock 0 $0 $0.5700 20 Jun 2025 Direct
Senti Biosciences, Inc. Chief Financial Officer, Head of Corporate Development Stock Option (Right to Buy) 152,000 01 Feb 2024 Direct
Kronos Bio, Inc. President & Interim CEO Employee Stock Option (Right to Buy) 0 20 Jun 2025 Direct

Insider Reports Filed by Deborah Knobelman

Symbol Company Period Transactions Value $ Form Type Role Filing Time
KRON Kronos Bio, Inc. 20 Jun 2025 2 -$79,471 4 President & Interim CEO 20 Jun 2025, 16:15
KRON Kronos Bio, Inc. 05 Jun 2025 1 -$21,554 4 President & Interim CEO 06 Jun 2025, 16:47
KRON Kronos Bio, Inc. 03 Jun 2024 2 $0 4 Chief Financial Officer 04 Jun 2024, 17:02
KRON Kronos Bio, Inc. 03 Jun 2024 0 $0 3 Chief Financial Officer 04 Jun 2024, 16:58
SNTI Senti Biosciences, Inc. 01 Feb 2024 2 $0 4 Chief Financial Officer, Head of Corporate Development 02 Feb 2024, 17:24
SNTI Senti Biosciences, Inc. 01 Feb 2023 1 $0 4 Chief Financial Officer 02 Feb 2023, 16:20
SNTI Senti Biosciences, Inc. 03 Oct 2022 2 $0 4 Chief Financial Officer 04 Oct 2022, 16:47
SNTI Senti Biosciences, Inc.\ 08 Jun 2022 0 $0 3 Chief Financial Officer 15 Jun 2022, 18:00